Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapyNikita Sharma, Sulagna Banerjee|Journal of Clinical Investigation|2019Cited by 211
Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic CancerVineet K. Gupta, Sulagna Banerjee|Cancer Research|2021Cited by 83
miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell deathZhiyu Chen, Ashok K. Saluja, Veena Sangwan et al.|Molecular Cancer|2013Cited by 64
Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathwayZhiyu Chen, Ashok K. Saluja, Vikas Dudeja et al.|Cancer Letters|2014Cited by 64
O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stabilityNikita Sharma, Sulagna Banerjee|Theranostics|2019Cited by 63